Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease

• Published in: Brain sciences 2020-05, Vol.10 (5), p.315
• Main Authors: Gonzalo-Gobernado, Rafael, Reimers, Diana, Casarejos, María José, Calatrava Ferreras, Lucía, Vallejo-Muñoz, Manuela, Jiménez-Escrig, Adriano, Diaz-Gil, Juan José, Ulzurrun de Asanza, Gonzalo M, Bazán, Eulalia
• Format: Article
• Language: English
• Subjects: 6-hydroxy-dopamine; 6-Hydroxydopamine; AMP; Astrocytes; Basal ganglia; Bilirubin; Blocking antibodies; Cell culture; Cyclic AMP response element-binding protein; Cytokines; Dopamine; Dopamine receptors; Embryos; Extracellular signal-regulated kinase; glial cultures; Growth factors; Laboratory animals; LGF; Liver; liver growth factor; Medical treatment; Mesencephalon; Microglia; Movement disorders; Neostriatum; Nervous system; Neurodegeneration; Neurodegenerative diseases; Neuronal-glial interactions; Neurons; Neuroprotection; Parkinson's disease; Parkinson´s disease; Phosphorylation; Substantia nigra; Tumor necrosis factor-TNF
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci10050315

Parkinson's disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (DA) neurons in the substantia nigra (SN), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. Current treatments relieve the symptoms of the disease, but none stop or delay neuronal degeneration. Liver growth factor (LGF) is an albumin-bilirubin complex that stimulates axonal growth in the striatum and protects DA neurons in the SN of 6-hydroxydopamine-lesioned rats. Our previous results suggested that these effects observed in vivo are mediated by microglia and/or astrocytes. To determine if these cells are LGF targets, E14 (embryos from Sprague Dawley rats of 14 days) rat mesencephalic glial cultures were used. Treatment with 100 pg/mL of LGF up-regulated the mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinases 1/2 (ERK1/2) and the cyclic AMP response element binding protein (CREB) phosphorylation in glial cultures, and it increased the microglia marker Iba1 and tumor necrosis factor alpha (TNF-alpha) protein levels. The treatment of E14 midbrain neurons with a glial-conditioned medium from LGF-treated glial cultures (GCM-LGF) prevented the loss of DA neurons caused by 6-hydroxy-dopamine. This neuroprotective effect was not observed when GCM-LGF was applied in the presence of a blocking antibody of TNF-alpha activity. Altogether, our findings strongly suggest the involvement of microglia and TNF-alpha in the neuroprotective action of LGF on DA neurons observed in vitro.